Elon Musk’s Drug Use Is the Latest Headache for Tesla’s Board

Elon Musk’s reported drug use has Tesla Inc. board members facing a familiar quandary: having to decide what, if anything, to do about the chief executive subjecting directors and shareholders alike to great financial and legal risk.

The Wall Street Journal’s article describing Musk’s history of recreational drug use and ongoing consumption of ketamine is the latest in a long line of tests for a board packed with the CEO’s acolytes — several of whom agreed less than six months ago to return $735 million to settle a lawsuit alleging they had excessively compensated themselves.

WATCH: Musk’s drug use LSD includes cocaine, ecstasy and psychedelic mushrooms, according to the Wall Street Journal reported.

Source: Bloomberg

Shareholders voiced dissatisfaction ...